SURGICAL INNOVATIONS GROUP PLC                         

                   DIRECTOR / PDMR SHAREHOLDING - CORRECTION                   

On 23 June 2008, Surgical Innovations Group plc ("the Company")
announced that Graham Bowland, Finance Director, had sold 258,749 ordinary
shares in the Company at a price of 2.58p per share (the "Shares") to his Self
Invested Personal Pension (the "SIPP"). The announcement stated that his
beneficial interest remained unchanged as a result of the transfer.

The Company has been notified that in November 2008 Mr. Bowland was informed
that, due a misunderstanding between himself and HSBC, his pension
administrators, the Shares were not sold to his SIPP and remain beneficially
held by Mr Bowland. Furthermore, on 20 June 2008 HSBC purchased a further
258,749 ordinary shares in the Company in the market for a price of 2.37p per
share on behalf of the SIPP.

Consequently, since 20 June 2008 Mr. Bowland's beneficial interest in the
Company has comprised 517,498 ordinary shares, representing 0.14 per cent. of
the issued share capital.

Enquiries:

Surgical Innovations Group plc                                   07715 612063
                                                                             
Graham Bowland                                                               
                                                                             
Hanson Westhouse Limited                                        0113 246 2610
                                                                             
Tim Feather / Matthew Johnson